Valsad: Gujarat Themis Biosyn Ltd. has begun commercial operations at its newly built Active Pharmaceutical Ingredient (API) manufacturing unit in Vapi GIDC.

The company, in a regulatory filing to stock exchanges, said, “We are pleased to inform you that today i.e. 6 May, 2025, the Company has commenced its commercial production at its newly set up API Plant situated at 69/C, GIDC Industrial Estate, Vapi-396195, Dist. Valsad, Gujarat, India.”

“This state-of-the-art, multi-purpose synthetic and fermentation-based API plant has been established for the production of various Active Pharmaceutical Ingredients (APIs) and Intermediates for use in the pharmaceutical industry. The facility will support the Company’s forward integration initiatives and strengthen its position in export markets, particularly in the United States and Europe,” the filing further said. DeshGujarat